SEC Form 4 · accession 0001209191-18-019837

INTEGRA LIFESCIENCES HOLDINGS CORP · IART

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CVP, CHIEF FINANCIAL OFFICER

Period of report

Mar 13, 2018

Accepted (ET)

Mar 15, 2018 · 4:20 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000917520

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 13, 2018	F	534	$56.23	D	41,840	D
Common Stock	Mar 13, 2018	F	2,002	$56.23	D	39,838	D
Common Stock	Mar 13, 2018	A	4,418	$0.00	A	44,256	D
Common Stock	Mar 14, 2018	S	3,052	$56.20	D	41,204	D
Common Stock^F1	Mar 14, 2018	S	5,717	$56.0512	D	35,487	D
Common Stock	Mar 14, 2018	F	436	$56.14	D	35,051	D
Common Stock	Mar 14, 2018	F	1,634	$56.14	D	33,417	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F2	$56.23	Mar 13, 2018	A	17,108	A	—	Mar 13, 2026	Common Stock	17,108	17,108	D

F1The price shown above represents the weighted average price of the shares sold. The range of sale prices was $56.05 to $56.09.
F233% of the shares of stock options will vest each of the first and second anniversaries of the grant date of 3/13/2018 and 34% of the shares of stock options will vest on the third anniversary of the grant date of 3/13/2018.